.RESEARCH EMPHASIZE.06 August 2024.
A large randomized controlled test with cisgender women highlights the obstacles of obedience to a regular oral preexposure prophylaxis routine as well as displays that twice-yearly treatment of lenacapavir can easily preserve efficient HIV deterrence amounts over 6 months.